These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 1470917)

  • 1. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene.
    Daniel MD; Kirchhoff F; Czajak SC; Sehgal PK; Desrosiers RC
    Science; 1992 Dec; 258(5090):1938-41. PubMed ID: 1470917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletion.
    Stahl-Hennig C; Dittmer U; Nisslein T; Pekrun K; Petry H; Jurkiewicz E; Fuchs D; Wachter H; Rud EW; Hunsmann G
    Immunol Lett; 1996 Jun; 51(1-2):129-35. PubMed ID: 8811357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live attenuated SIV vaccines are not effective in a postexposure vaccination model.
    Linhart H; Gundlach BR; Sopper S; Dittmer U; Mätz-Rensing K; Kuhn EM; Müller J; Hunsmann G; Stahl-Hennig C; Uberla K
    AIDS Res Hum Retroviruses; 1997 May; 13(7):593-9. PubMed ID: 9135877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus.
    Dittmer U; Nisslein T; Bodemer W; Petry H; Sauermann U; Stahl-Hennig C; Hunsmann G
    Virology; 1995 Oct; 212(2):392-7. PubMed ID: 7571408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection by live, attenuated simian immunodeficiency virus against heterologous challenge.
    Wyand MS; Manson K; Montefiori DC; Lifson JD; Johnson RP; Desrosiers RC
    J Virol; 1999 Oct; 73(10):8356-63. PubMed ID: 10482586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants.
    Rud EW; Cranage M; Yon J; Quirk J; Ogilvie L; Cook N; Webster S; Dennis M; Clarke BE
    J Gen Virol; 1994 Mar; 75 ( Pt 3)():529-43. PubMed ID: 8126450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques.
    Baba TW; Jeong YS; Pennick D; Bronson R; Greene MF; Ruprecht RM
    Science; 1995 Mar; 267(5205):1820-5. PubMed ID: 7892606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys.
    Titti F; Sernicola L; Geraci A; Panzini G; Di Fabio S; Belli R; Monardo F; Borsetti A; Maggiorella MT; Koanga-Mogtomo M; Corrias F; Zamarchi R; Amadori A; Chieco-Bianchi L; Verani P
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2529-39. PubMed ID: 9349474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with Live Attenuated Simian Immunodeficiency Virus (SIV) Protects from Mucosal, but Not Necessarily Intravenous, Challenge with a Minimally Heterologous SIV.
    Sutton MS; Burns CM; Weiler AM; Balgeman AJ; Braasch A; Lehrer-Brey G; Friedrich TC; O'Connor SL
    J Virol; 2016 Jun; 90(12):5541-5548. PubMed ID: 26962218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus.
    Stahl-Hennig C; Dittmer U; Nisslein T; Petry H; Jurkiewicz E; Fuchs D; Wachter H; Mätz-Rensing K; Kuhn EM; Kaup FJ; Rud EW; Hunsmann G
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():2969-81. PubMed ID: 9000087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.
    Almond N; Kent K; Cranage M; Rud E; Clarke B; Stott EJ
    Lancet; 1995 May; 345(8961):1342-4. PubMed ID: 7752758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of mismatch of Env sequences on vaccine protection by live attenuated simian immunodeficiency virus.
    Manrique J; Piatak M; Lauer W; Johnson W; Mansfield K; Lifson J; Desrosiers R
    J Virol; 2013 Jul; 87(13):7246-54. PubMed ID: 23637396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine effect using a live attenuated nef-deficient simian immunodeficiency virus of African green monkeys in the absence of detectable vaccine virus replication in vivo.
    Beer B; Baier M; zur Megede J; Norley S; Kurth R
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):4062-7. PubMed ID: 9108105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Env-independent protection induced by live, attenuated simian immunodeficiency virus vaccines.
    Gundlach BR; Reiprich S; Sopper S; Means RE; Dittmer U; Mätz-Rensing K; Stahl-Hennig C; Uberla K
    J Virol; 1998 Oct; 72(10):7846-51. PubMed ID: 9733821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy of nonpathogenic nef-deleted SHIV vaccination combined with recombinant IFN-gamma administration against a pathogenic SHIV challenge in rhesus monkeys.
    Kaneyasu K; Kita M; Ohkura S; Yamamoto T; Ibuki K; Enose Y; Sato A; Kodama M; Miura T; Hayami M
    Microbiol Immunol; 2005; 49(12):1083-94. PubMed ID: 16365534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: no detection of reactivation after stimulation with a recall antigen.
    Sernicola L; Corrias F; Koanga-Mogtomo ML; Baroncelli S; Di Fabio S; Maggiorella MT; Belli R; Michelini Z; Macchia I; Cesolini A; Cioè L; Verani P; Titti F
    Virology; 1999 Apr; 256(2):291-302. PubMed ID: 10191194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simian immunodeficiency virus promoter exchange results in a highly attenuated strain that protects against uncloned challenge virus.
    Blancou P; Chenciner N; Ho Tsong Fang R; Monceaux V; Cumont MC; Guétard D; Hurtrel B; Wain-Hobson S
    J Virol; 2004 Feb; 78(3):1080-92. PubMed ID: 14722263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV.
    Marthas ML; Miller CJ; Sutjipto S; Higgins J; Torten J; Lohman BL; Unger RE; Ramos RA; Kiyono H; McGhee JR
    J Med Primatol; 1992; 21(2-3):99-107. PubMed ID: 1433273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunity induced by live attenuated simian immunodeficiency virus.
    Johnson RP; Desrosiers RC
    Curr Opin Immunol; 1998 Aug; 10(4):436-43. PubMed ID: 9722920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain.
    Gundlach BR; Lewis MG; Sopper S; Schnell T; Sodroski J; Stahl-Hennig C; Uberla K
    J Virol; 2000 Apr; 74(8):3537-42. PubMed ID: 10729127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.